Disease Burden and Impact of Certolizumab Pegol Treatment on Workplace and Household Productivity Across Working Age Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis Patients

被引：0
|
作者：
Kavanaugh, Arthur F. [1 ]
Mease, Philip J. [2 ,3 ]
Purcaru, Oana [4 ]
van der Heijde, Desiree [5 ]
机构：
[1] UC San Diego Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] UCB Pharma, 208 Bath Rd, Slough, Berks, England
[5] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1731
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
    Philip J. Mease
    Mei Liu
    Sabrina Rebello
    Hyungjoo Kang
    Esther Yi
    Yujin Park
    Jeffrey D. Greenberg
    Rheumatology and Therapy, 2019, 6 : 529 - 542
  • [22] STRINGENT THRESHOLDS OF DISEASE CONTROL ARE ASSOCIATED WITH REDUCED BURDEN ON PAID AND HOUSEHOLD WORK PRODUCTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS DURING LONG-TERM TREATMENT WITH CERTOLIZUMAB PEGOL
    Tillett, W.
    Coates, L. C.
    Nurminen, T.
    Kiri, S.
    Mease, P.
    VALUE IN HEALTH, 2020, 23 : S411 - S411
  • [23] SERUM CALPROTECTIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS
    Jarlborg, Matthias
    Courvoisier, Delphine
    Lamacchia, Celine
    Martinez-Prat, Laura
    Bentow, Chelsea
    Mahler, Michael
    Finckh, Axel
    Gabay, Cem
    Nissen, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1588 - 1588
  • [24] Reduced Burden on Paid and Household Work Productivity with Stringent Thresholds of Disease Control: Further Results from Long-Term Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis
    Tillett, William
    Coates, Laura
    Kiri, Sandeep
    Taieb, Vanessa
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3815 - 3817
  • [25] Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis
    Reina, D.
    Vidal, D.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (08): : 703 - 704
  • [26] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Tzanetakos, C.
    Vassilopoulos, D.
    Kourlaba, G.
    Christou, P.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A638 - A639
  • [27] Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
    van der Heijde, D.
    Deodhar, A.
    Fleischmann, R.
    Mease, P. J.
    Rudwaleit, M.
    Nurminen, T.
    Davies, O.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (07) : 1030 - 1039
  • [28] DISEASE ACTIVITY AND CLINICAL RESPONSE EARLY IN THE COURSE OF TREATMENT PREDICTS LONG-TERM OUTCOMES IN AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL
    van der Heijde, D.
    Deodhar, A.
    Fleischmann, R.
    Rudwaleit, M.
    Davies, O.
    Nurminen, T.
    Mease, P. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 786 - 786
  • [29] REMISSION PERSISTENCE IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS UNDER BIOLOGIC TREATMENT
    Avila-Ribeiro, Pedro
    Fonseca, Joao Eurico
    Vieira-Sousa, Elsa
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1027 - 1028
  • [30] DRUG SURVIVAL ON CERTOLIZUMAB AND PREDICTORS THEREOF IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL-SPONDYLOARTHRITIS FROM THE APULIAN BIOPURE REGISTRY
    Semeraro, A.
    Carlino, G.
    Bucci, R.
    D'Onofrio, F.
    Falappone, P. C.
    Lopriore, S.
    Marsico, A.
    Maruotti, N.
    Mazzotta, D.
    Muratore, M.
    Quarta, L.
    Santo, L.
    Zuccaro, C.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1374 - 1374
12345